Some price data may be temporarily unavailable.
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
GLOBAL BLOOD THERAPEUTICS INC COM USD0.001
The blood-disorder specialist sells itself in a deal with an enterprise value of around $5.4 billion.
Pfizer emerges as the lead suitor for the rare-disease company.
GBT earnings call for the period ending March 31, 2022.
GBT earnings call for the period ending December 31, 2021.
GBT earnings call for the period ending September 30, 2021.
GBT earnings call for the period ending June 30, 2021.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
